课题基金 / 基金详情

NOVEL CYCLIC-PEPTIDE-BASED ANTIMITOTICS

NOVEL CYCLIC-PEPTIDE-BASED ANTIMITOTICS
新型环肽抗有丝分裂剂
批准号:
2862902
负责人:
Robert SCOTT LOKEY
金额:
$3.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
未结题
起止时间:
1999-07-01 至

项目摘要

项目成果

Robert SCOTT LOKEY的其他基金

相似基金

相关文献

中文摘要
翻译
我们将合成一个小的七肽支架库,以探讨支架构象对环化和细胞通透性的影响。 我们将选择几种新型的细胞可渗透的环状支架,用于构建潜在的蛋白质配体库,并在许多不同的试验中筛选它们对细胞周期的影响。 将选择几种活性化合物进行进一步研究。 我们特别感兴趣的是通过直接干扰细胞周期蛋白B的降解或通过靶向有丝分裂纺锤体的组分并因此触发有丝分裂检查点途径而在有丝分裂中阻滞细胞的化合物。
英文摘要
We will synthesize a small library of heptapeptide scaffolds to explore the effects of scaffold conformation on cyclization and cell permeability. We will select several novel cell-permeable cyclic scaffolds for elaboration into libraries of potential protein ligands and screen them for effects on the cell cycle in a number of different assays. Several active compounds will be chosen for further study. We are particularly interested in compounds that arrest cells in mitosis by directly perturbing the degradation of cyclin B or by targeting components of the mitotic spindle and thus triggering the mitotic checkpoint pathway.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing the basic science of membrane permeability in macrocyclic peptides
Upgrade of core imaging instrumentation and robotics for the UCSC Chemical Screening Center
Cyclic peptide permeability
Cyclic peptide permeability
海外基金